CIC
SGRY icon

Chase Investment Counsel’s Surgery Partners SGRY Stock Holding History

Chase Investment Counsel’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-51,987
Closed -$2.34M – 127
2023
Q2 		$2.34M Buy
+51,987
New +$1.98M 1.18% 36

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chase Investment Counsel's SGRY Position: Q3 2023 in Review

Chase Investment Counsel sold out of Surgery Partners (SGRY) in Q3 2023, closing a stake of 51,987 shares — an estimated $2.34M sold.

Chase Investment Counsel first reported a position in SGRY in Q2 2023 and held it in 1 quarter. The position peaked at $2.34M in Q2 2023. 164 funds tracked by Wall St. Rank hold SGRY as of Q3 2023.

  • Chase Investment Counsel reported no remaining Surgery Partners position as of Q3 2023 after selling out during the quarter.
  • Chase Investment Counsel sold 51,987 Surgery Partners shares in Q3 2023, an estimated $2.34M.
  • Chase Investment Counsel first reported a position in Surgery Partners in Q2 2023 and held it in 1 quarter.
  • Chase Investment Counsel's Surgery Partners position peaked at $2.34M in Q2 2023.
  • 164 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2023.

Based on Chase Investment Counsel's 13F filing for Q3 2023, filed 8 Nov 2023.